Phase 4 Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with hemophilia A or B with inhibitors
- People who are 12 years of age or older
- People who are able to understand and follow the study requirements, or who have a parent or legal guardian who is able to do so on their behalf
- People who have read, understood, and signed a consent form agreeing to take part
- People who are able to provide past medical records showing previous inhibitor level results
- People who are willing and able to use a mobile app or paper diary to record bleeding events and medication use
Who may not be able to join:
- People who have an additional blood clotting disorder on top of their hemophilia A or B
- People who have a known or suspected intolerance or allergic reaction to SEVENFACT® or any of its ingredients
- People who have a known allergy or sensitivity to rabbits or rabbit proteins
- People who are receiving a preventive bleeding treatment (drug or biological therapy) that the FDA has not approved for that specific use
- People who have had an investigational medical device implanted in the 6 months before the study
- People who have taken an investigational (unapproved) drug within 30 days of the study's starting visit
- People who have a planned elective surgery scheduled during the time they would be taking part in the study
- People who have a life-threatening illness, or any other disease or condition that the study doctor believes could put them at risk or interfere with the study (for example, a history of not responding to bypassing treatments, or a history of blood clot disorders)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tammuella Chrisentery-Singleton, MD, American Thrombosis and Hemostasis Network
Phone: (800)-360-2846
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants and percentage of Safety Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.